Maximo F. Nougues - Feb 10, 2023 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role: Chief Financial Officer
Signature: /s/ Gordon Esplin as attorney-in-fact for Maximo F. Nougues
Stock symbol: PBYI
Transactions as of: Feb 10, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/14/2023, 03:53 PM
Previous filing: Jan 5, 2023
Next filing: Jul 6, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBYI	Common Stock	Award	$0	+58.6K	+58.35%	$0.00	159K	Feb 10, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PBYI	Stock Option (Right to Buy)	Award	$0	+81.4K		$0.00	81.4K	Feb 10, 2023	Common Stock	81.4K	$4.39	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2023, January 1, 2024, July 1, 2024 and January 1, 2025, subject to the Grantee's continued service with the Company through the applicable vesting date.
F2	Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2023, January 1, 2024, July 1, 2024 and January 1, 2025, subject to the Optionee's continued service with the Company through the applicable vesting date.